Prognostic value of DNA cytometry in patients with non-small cell lung carcinoma

被引：0
|
作者：
Skuballa, A [1 ]
Starke, U [1 ]
Achatzy, R [1 ]
Hutschenreiter, J [1 ]
机构：
[1] Stadt Klinikum St Georg, Klin Thoraxchirurg, Leipzig, Germany
来源：
6TH EUROPEAN CONFERENCE ON GENERAL THORACIC SURGERY | 1998年
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
DNA flow cytometry;was used to study ploidy and cell cycle phase in patients with non - small cell lung carcinoma. A total number of 80 tumor samples were investigated. Cell cycle analysys was possible in 42 tumors. 79% of the tumors were aneuploid and 21% had diploid tumors. There was a correlation between high S-phase fraction in aneuploid tumors and lower S-phase fraction in diploid tumors. Patients with a lower S-phase fraction had a tendency to better survival, both diploid and aneuploid tumors.
引用
收藏
页码：89 / 92
页数：4
相关论文
共 50 条
  • [11] Prognostic value and therapeutic consequences of vascular invasion in non-small cell lung carcinoma
    Bodendorf, Marc Oliver
    Haas, Victor
    Laberke, Hans-Gerd
    Blumenstock, Gunnar
    Wex, Peter
    Graeter, Thomas
    LUNG CANCER, 2009, 64 (01) : 71 - 78
  • [12] Neural networks as a prognostic tool for patients with non-small cell carcinoma of the lung
    Bellotti, M
    Elsner, B
    De Lima, AP
    Esteva, H
    Marchevsky, AM
    MODERN PATHOLOGY, 1997, 10 (12) : 1221 - 1227
  • [13] THE PROGNOSTIC VALUE OF LYMPHANGIOGENESIS ON NON-SMALL CELL LUNG CANCER
    Yang Shentu
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1493 - S1494
  • [14] Non-small cell lung cancer - Morphology and DNA flow cytometry
    Desinan, L
    Scott, CA
    Pizzolitto, S
    Avellini, C
    Rimondi, G
    Bardus, P
    Rizzi, V
    Talmassons, G
    Puricelli, C
    Beltrami, CA
    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY, 1996, 18 (06): : 438 - 452
  • [15] Prognostic value of phospho-Akt in patients with non-small cell lung carcinoma: A meta-analysis
    Yang, Yang
    Luo, Jialin
    Zhai, Xiaoming
    Fu, Zhiqin
    Tang, Zhongzhu
    Liu, Luying
    Chen, Ming
    Zhu, Yuan
    INTERNATIONAL JOURNAL OF CANCER, 2014, 135 (06) : 1417 - 1424
  • [16] Prognostic Value of Survivin in Patients with Non-Small Cell Lung Carcinoma: A Systematic Review with Meta-Analysis
    Zhang, Lou Qian
    Wang, Jun
    Jiang, Feng
    Xu, Lin
    Liu, Fu Yin
    Yin, Rong
    PLOS ONE, 2012, 7 (03):
  • [17] Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients
    Fan, Jinping
    Yu, Haiying
    Lv, Ying
    Yin, Liguo
    TUMOR BIOLOGY, 2016, 37 (02) : 1949 - 1958
  • [18] Prognostic and predictive biomarkers in non-small cell lung carcinoma
    Odintsov, Igor
    Sholl, Lynette m.
    PATHOLOGY, 2024, 56 (02) : 192 - 204
  • [19] Prognostic Value of the Lung Immune Prognostic Index for Patients Treated for Metastatic Non-Small Cell Lung Cancer
    Kazandjian, Dickran
    Gong, Yutao
    Keegan, Patricia
    Pazdur, Richard
    Blumenthal, Gideon M.
    JAMA ONCOLOGY, 2019, 5 (10) : 1481 - 1485
  • [20] Prognostic value of aspartyl (asparaginyl)-β-hydroxylase/humbug expression in non-small cell lung carcinoma
    Luu, Martin
    Sabo, Edmond
    de la Monte, Suzanne M.
    Greaves, Wesley
    Wang, JiYi
    Tavares, Rosemarie
    Simao, Lelia
    Wands, Jack R.
    Resnick, Murray B.
    Wang, LiJuan
    HUMAN PATHOLOGY, 2009, 40 (05) : 639 - 644
12345